Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Christopher, Pocock"'
Autor:
Farhad Ravandi, Gail J. Roboz, Andrew H. Wei, Hartmut Döhner, Christopher Pocock, Dominik Selleslag, Pau Montesinos, Hamid Sayar, Maurizio Musso, Angela Figuera-Alvarez, Hana Safah, William Tse, Sang Kyun Sohn, Devendra Hiwase, Timothy Chevassut, Francesca Pierdomenico, Ignazia La Torre, Barry Skikne, Rochelle Bailey, Jianhua Zhong, C. L. Beach, Herve Dombret
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-14 (2021)
Abstract Background Most older patients with acute myeloid leukemia (AML) who attain morphologic remission with intensive chemotherapy (IC) will eventually relapse and post-relapse prognosis is dismal. In the pivotal QUAZAR AML-001 trial, oral azacit
Externí odkaz:
https://doaj.org/article/643e4039c05b4d0693acd3685dcccc4b
Autor:
Daniele Avenoso, Dragana Milojkovic, James Clark, Christopher Pocock, Victoria Potter, Deborah Yallop, Guy Hannah
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 215-217 (2022)
Abstract During the COVID‐19 pandemic, access to health services has been considerably restricted and furthermore, patients have been reluctant to attend for routine monitoring, and this may have had a negative impact in the management of patients
Externí odkaz:
https://doaj.org/article/19d861bada1f450b931205d093dc7088
Autor:
Gail J. Roboz, Hartmut Döhner, Christopher Pocock, Herve Dombret, Farhad Ravandi, Jun Ho Jang, Dominik Selleslag, Jiři Mayer, Uwe M. Martens, Jane Liesveld, Teresa Bernal, Ming Chung Wang, Peiwen Yu, Ling Shi, Shien Guo, Ignazia La Torre, Barry Skikne, Qian Dong, Julia Braverman, Salem Abi Nehme, C.L. Beach, Andrew H. Wei
Publikováno v:
Haematologica, Vol 106, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/7e38f7b13b954164a5cb827b147a1c00
Autor:
Andrew M. Evens, Joseph M. Connors, Anas Younes, Stephen M. Ansell, Won Seog Kim, John Radford, Tatyana Feldman, Joseph Tuscano, Kerry J. Savage, Yasuhiro Oki, Andrew Grigg, Christopher Pocock, Monika Dlugosz-Danecka, Keenan Fenton, Andres Forero-Torres, Rachael Liu, Hina Jolin, Ashish Gautam, Andrea Gallamini
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Effective and tolerable treatments are needed for older patients with classical Hodgkin lymphoma. We report results for older patients with classical Hodgkin lymphoma treated in the large phase III ECHELON-1 study of frontline brentuximab vedotin plu
Externí odkaz:
https://doaj.org/article/05ad3efbc3ef4677a99a0a0fd38b3d53
Autor:
Michael L, Wang, Wojciech, Jurczak, Mats, Jerkeman, Judith, Trotman, Pier L, Zinzani, David, Belada, Carola, Boccomini, Ian W, Flinn, Pratyush, Giri, Andre, Goy, Paul A, Hamlin, Olivier, Hermine, José-Ángel, Hernández-Rivas, Xiaonan, Hong, Seok Jin, Kim, David, Lewis, Yuko, Mishima, Muhit, Özcan, Guilherme F, Perini, Christopher, Pocock, Yuqin, Song, Stephen E, Spurgeon, John M, Storring, Jan, Walewski, Jun, Zhu, Rui, Qin, Todd, Henninger, Sanjay, Deshpande, Angela, Howes, Steven, Le Gouill, Martin, Dreyling, Joseph C, Gardiner
Publikováno v:
New England Journal of Medicine. 386:2482-2494
Ibrutinib, a Bruton's tyrosine kinase inhibitor, may have clinical benefit when administered in combination with bendamustine and rituximab and followed by rituximab maintenance therapy in older patients with untreated mantle-cell lymphoma.We randoml
Autor:
Uwe M. Martens, Jun Ho Jang, Farhad Ravandi, Julia Braverman, Shien Guo, Ming Chung Wang, Jane L. Liesveld, C.L. Beach, Teresa Bernal, Barry S. Skikne, Christopher Pocock, Jiří Mayer, Peiwen Yu, Hartmut Döhner, Gail J. Roboz, Qian Dong, Ling Shi, Dominik Selleslag, Andrew H. Wei, Salem Abi Nehme, Ignazia La Torre, Hervé Dombret
Publikováno v:
Haematologica. 106:3240-3244
Autor:
Jianhua Zhong, Hamid Sayar, Dominik Selleslag, Christopher Pocock, C.L. Beach, Farhad Ravandi, Rochelle Bailey, Pau Montesinos, Angela Figuera-Alvarez, Sang Kyun Sohn, Andrew H. Wei, Hervé Dombret, William Tse, Hartmut Döhner, Francesca Pierdomenico, Maurizio Musso, Gail J. Roboz, Timothy Chevassut, Hana Safah, Devendra K Hiwase, Ignazia La Torre, Barry S. Skikne
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-14 (2021)
JOURNAL OF HEMATOLOGY & ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Hematology & Oncology
JOURNAL OF HEMATOLOGY & ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Hematology & Oncology
Background Most older patients with acute myeloid leukemia (AML) who attain morphologic remission with intensive chemotherapy (IC) will eventually relapse and post-relapse prognosis is dismal. In the pivotal QUAZAR AML-001 trial, oral azacitidine mai
Autor:
Andres Forero-Torres, Tatyana Feldman, Christopher Pocock, Andrea Gallamini, John Radford, Joseph Tuscano, Yasuhiro Oki, Andrew M. Evens, Hina Jolin, Anas Younes, Keenan Fenton, Stephen M. Ansell, Joseph M. Connors, Andrew Grigg, Won Seog Kim, Ashish Gautam, Kerry J. Savage, Rachael Liu, Monika Długosz-Danecka
Publikováno v:
Evens, A M, Connors, J M, Younes, A, Ansell, S M, Kim, W S, Radford, J, Feldman, T, Tuscano, J, Savage, K J, Oki, Y, Grigg, A, Pocock, C, Dlugosz-Danecka, M, Fenton, K, Forero-Torres, A, Liu, R, Jolin, H, Gautam, A & Gallamini, A 2021, ' Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma : a detailed analysis from the phase III ECHELON-1 study ', Haematologica . https://doi.org/10.3324/haematol.2021.278438
Effective and tolerable treatments are needed for older patients with classical Hodgkin lymphoma. We report results for older patients with classical Hodgkin lymphoma treated in the large phase III ECHELON-1 study of frontline brentuximab vedotin plu
Autor:
Victoria Potter, Daniele Avenoso, Dragana Milojkovic, Guy Hannah, James Clark, Christopher Pocock, Deborah Yallop
Publikováno v:
eJHaem. 3:215-217
Autor:
Simon Rule, Paul Smith, Peter W.M. Johnson, Simon Bolam, George Follows, Joanne Gambell, Peter Hillmen, Andrew Jack, Stephen Johnson, Amy A Kirkwood, Anton Kruger, Christopher Pocock, John F. Seymour, Milena Toncheva, Jan Walewski, David Linch
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Mantle cell lymphoma is an incurable and generally aggressive lymphoma that is more common in elderly patients. Whilst a number of different chemotherapeutic regimens are active in this disease, there is no established gold standard therapy. Rituxima
Externí odkaz:
https://doaj.org/article/f337005569d54ae79221956560b278ff